loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Open ICICI
3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

+91

BLOG

Glenmark Pharma announced the launch of Winlevi across key markets in Europe

ICICIdirect Research 12 Jun 2026 DISCLAIMER

News: Glenmark Pharma announced the launch of Winlevi across key markets in Europe. The medication is indicated for the treatment of acne vulgaris. Glenmark has initiated direct launches in several European markets, including the Nordics, Central and Eastern Europe, and Spain. In Portugal, the Company has launched the product through a strategic partner. Glenmark is also advancing additional launches through strategic partnerships across other European markets.

View: The Launch of Winlevi in Europe is in line with Glenmark's strategy to focuses on expanding differentiated therapies across global markets. The product is expected to achieve peak sales of ~US$40-50 million in EU over the period of 3-5 years. However, as product being part innovative dermatology portfolio, we believe it to fetch better margins.

Impact: Positive

Download ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere

Download ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere